H19 and Cholestatic liver disease: Since patients with liver cirrhosis have serum EVs carrying elevated levels of H19 compared to those from healthy individuals, H19-carrying EVs may play a critical role in the pathogenesis of cholestatic liver diseases and liver cirrhosis (24).